Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Collexis was a leading developer of semantic search and knowledge discovery software specifically designed for the life sciences, healthcare, and academic research sectors. The company's proprietary "Fingerprinting" technology allowed for the automated extraction of key concepts from unstructured text, enabling researchers and institutions to identify experts, discover trends, and manage intellectual property. Following its acquisition by Elsevier in 2010, its technology was integrated into Elsevier's research management tools, such as SciVal and Pure. The company played a significant role in the early development of research networking and expert profiling systems for major institutions like the NIH and various global universities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Collexis.